APOE and Alzheimer disease: Likewise, distinct patterns of striatal atrophy and increased Aβ deposition, but not metabolic change, have been observed in ApoE ε4 carriers compared to non-carriers in Alzheimer's disease (Cohen and Klunk, 2014; Pievani et al., 2013).